Puma Biotechnology Inc. (PBYI)
NASDAQ · Healthcare
Puma Biotechnology Inc. Shareholder Equity 2017–2025
Puma Biotechnology Inc. annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Puma Biotechnology Inc. shareholder equity as of December 31, 2025: 130.3M, a 41.48% increase year-over-year.
- Puma Biotechnology Inc. shareholder equity for 2025 were 130.3M, a 41.48% increase from 2024.
- Puma Biotechnology Inc. shareholder equity for 2024 were 92.1M, a 72.38% increase from 2023.
- Puma Biotechnology Inc. shareholder equity for 2023 were 53.4M, a 147.33% increase from 2022.
- Puma Biotechnology Inc. shareholder equity for 2022 were 21.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Puma Biotechnology Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $130 |
| 2024 | $92 |
| 2023 | $53 |
| 2022 | $22 |
| 2021 | $-2 |
| 2020 | $-6 |
| 2019 | $17 |
| 2018 | $34 |
| 2017 | $53 |
Puma Biotechnology Inc. Shareholder Equity — FAQ
Puma Biotechnology Inc. (PBYI) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PBYI's shareholder equity history?
The chart and table above show Puma Biotechnology Inc.'s shareholder equity by year and by quarter, including the growth rate.